Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 50015391
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155562(1-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)...)
Affinity DataIC50: 52nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155567(1-(3-Dimethylamino-phenyl)-3-[4-methyl-3-(4-pyridi...)
Affinity DataIC50: 56nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155560(1-(3-Chloro-phenyl)-3-[4-methyl-3-(4-pyridin-3-yl-...)
Affinity DataIC50: 175nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155568(1-(3-Diethylamino-phenyl)-3-[4-methyl-3-(4-pyridin...)
Affinity DataIC50: 280nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155567(1-(3-Dimethylamino-phenyl)-3-[4-methyl-3-(4-pyridi...)
Affinity DataIC50: 573nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155562(1-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)...)
Affinity DataIC50: 720nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155563(1-{2-[(Cyclohexyl-methyl-amino)-methyl]-phenyl}-3-...)
Affinity DataIC50: 870nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155565(Piperidine-1-carboxylic acid [4-methyl-3-(4-pyridi...)
Affinity DataIC50: 930nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155574(1-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155568(1-(3-Diethylamino-phenyl)-3-[4-methyl-3-(4-pyridin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155560(1-(3-Chloro-phenyl)-3-[4-methyl-3-(4-pyridin-3-yl-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155557(1-(4-Diethylamino-phenyl)-3-[4-methyl-3-(4-pyridin...)
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155561(4-Methyl-piperazine-1-carboxylic acid [4-methyl-3-...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase ABL1(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155559(1-(4-Dimethylamino-phenyl)-3-[4-methyl-3-(4-pyridi...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibitory concentration required to inhibit Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155575(1-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)...)
Affinity DataIC50: 9.00E+3nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155559(1-(4-Dimethylamino-phenyl)-3-[4-methyl-3-(4-pyridi...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155557(1-(4-Diethylamino-phenyl)-3-[4-methyl-3-(4-pyridin...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetBreakpoint cluster region protein(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM50155565(Piperidine-1-carboxylic acid [4-methyl-3-(4-pyridi...)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory concentration required to inhibit Bcr-Abl tyrosine kinaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed